All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.
Now you can personalise
your Multiple Myeloma Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for youFind out more
Checkpoint inhibitors target molecules responsible for the regulation of the immune response. The expression of programmed cell death protein 1 (PD-1) and its ligand, PD-L1, suppresses T cell activation. In response to a normal immune challenge, this pathway prevents hyperstimulation, and in malignancy this can halt immune responses against the tumor, enabling unimpeded progression.
Save to your areas of interest